← Back to Clinical Trials
Recruiting NCT07192094

NCT07192094 A Reinforced Mindfulness-Based Intervention to Reduce Problematic Drinking Among Hispanic Emerging Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07192094
Status Recruiting
Phase
Sponsor Florida International University
Condition MBSR
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2026-01-27
Primary Completion 2028-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Mindfulness Sessions - 8 Week Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2026-01-27 with a primary completion date of 2028-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a trial to evaluate a mindfulness program designed for Hispanic young adults. Participants will be randomly assigned to one of two groups: (1) an in-person, 8-week mindfulness program (one 1.5-hour session per week at FIU's MMC campus), or (2) an assessment-only control group. Regardless of group assignment. Participants will be asked to complete online surveys at baseline, after an 8-week period, and again one month later. They will also be asked to provide a fingerpick blood sample and have their heart rate and blood pressure measured at four timepoints: baseline, 1 month, 2 months, and 3 months after baseline. Participation will involve up to 16 hours over approximately 14 weeks. This includes time for completing baseline assessments, participating in the 8-week intervention (if assigned), and completing post-program and follow-up assessments. There are no serious risks of participating in this study, but some of the questions during the assessments, interview, or the fingerpick may cause you discomfort. The main benefit from participating in this clinical trial is that participants may experience personal benefits from learning mindfulness techniques.

Eligibility Criteria

Inclusion Criteria: * self-identified Hispanic, * 18-25 years old, * engaged in 2 or more occasions of heavy episodic drinking occasions (HED) (4/5 drinks in one sitting for females/males) during the previous 30-days * actively enrolled FIU student. Exclusion Criteria Participants will be flagged for exclusion criteria if they report any of the following: * Five or more binge drinking episodes (5+ drinks in one sitting) in the past 30 days, which averages more than once per week. * Weekly or more frequent use of other substances, including non-prescribed prescription drugs, illegal drugs, inhalants, or synthetic drugs.

Contact & Investigator

Central Contact

Michelle Hospital, PhD, LMHC

✉ hospitam@fiu.edu

📞 305-505-9337

Principal Investigator

Michelle Hospital, PhD, LMHC

PRINCIPAL INVESTIGATOR

Florida International University

Frequently Asked Questions

Who can join the NCT07192094 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying MBSR. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07192094 currently recruiting?

Yes, NCT07192094 is actively recruiting participants. Contact the research team at hospitam@fiu.edu for enrollment information.

Where is the NCT07192094 trial being conducted?

This trial is being conducted at Miami, United States.

Who is sponsoring the NCT07192094 clinical trial?

NCT07192094 is sponsored by Florida International University. The principal investigator is Michelle Hospital, PhD, LMHC at Florida International University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology